Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenosar
NL-OMON58624Phase 4Completed
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in sarcoidosis comparing Azithromycin + doxycycline with Placebo (2 arms). Primary endpoints: Reduction of sarcoidosis-related inflammation and Reduction of inflammatory activity in Cutibacterium acnes-related sarcoidosis. Started Aug 2021; status: completed.
02
Drugs
azithromycindoxycycline
03
Conditions
sarcoidosis
Beyond the preview
Go deeper on NL-OMON58624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58624.